.JPG)
The Authentication Solution Providers’ Association (ASPA), the leading industry body dedicated to anti-counterfeiting and traceability, presented a thought leadership paper
As part of a recent examination, the regulator Subject Expert Committee (SEC), under the Central Drugs Standard Control Organisation (CDSCO), directed Akum Pharmaceuticals to submit supportive safety data
The Government of Karnataka state has made a formal notification to merge the AYUSH Drug Licensing Authority, Drug Enforcement Division, and Drug Testing Laboratories in the State Food and Drug Administration
Hyderabad pharmaceutical company Aurobindo Pharma said on July 30 that its US-based unit, Aurobindo Pharma USA Inc., has signed a binding agreement to buy Lannett Company LLC
The much-proposed 25% general tariff, which US President Donald Trump revealed on August 1, 2025, will exempt Indian drug exports to the US. But the mood is far from festive.
Merck & Co. has initiated a major cost-cutting program that will save $3 billion by 2027. The multiyear program of optimization, outlined in its Q2 2025 earnings announcement
The Central Drugs Standard Control Organisation (CDSCO) has introduced a QR Code-based appointment booking for stakeholders visiting CDSCO’s headquarters located in the FDA Bhawan at New Delhi
GlaxoSmithKline (GSK) recently revealed that it had allied with Chinese Hengrui Pharma to co-develop up to 12 novel medicines. The collaboration was valued at potentially up to $12 billion and is intended to support GSK’s long-term growth
The Delhi High Court has declined to issue directions to Zydus Lifesciences to disclose the manufacturing process of its breast cancer drug Sigrima, following a plea by Swiss multinational F. Hoffmann-La Roche.
Under the Production Linked Incentive (PLI) Scheme aimed at increasing domestic manufacturing of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs)
.jpg)
, CDSCO.jpg)